Neuropsychological tool to measure how people with Alzheimer's perceive and think about time

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project uses the Chronos battery to quantify four aspects of temporal processing—simultaneity and order, duration processing, subjective passage of time, and mental time travel—in people with Alzheimer's disease. Participants are recruited from the neurology unit at Caen Hospital and must have deficits in at least two cognitive domains including episodic memory, with exclusions for major psychiatric disorders, significant head trauma, or medications that alter cognition. Each participant completes a standardized set of behavioral and neuropsychological tasks spanning perception to memory to build individual time-processing profiles. The goal is to develop a practical clinical tool to detect and monitor time-related cognitive changes across aging and Alzheimer's progression.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* No objection from the participant or their legal representative, if applicable, prior to or during the assessment
* Deficit in at least two cognitive functions, including episodic memory.

Exclusion Criteria:

* History of head trauma with loss of consciousness lasting more than 1 hour
* Presence of clinically significant major psychiatric disorders (according to DSM-IV-TR criteria)
* Use of medications likely to alter cognitive and/or brain function (decision by the principal investigator)

Where it's running

• Caen Hospital, neurology Unit
  Caen, France Recruiting

Study contacts

• Study coordinator: Marianne Hebert
• Email: hebert-maria@chu-caen.fr
• Phone: +33231065728

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease in Real World Practice

  This study will look at real-world safety and effectiveness of disease-modifying therapy (DMT) in adults with MCI or Alzheimer's dementia by comparing those who receive DMT in routine care to those who do not.

  Recruiting Fudan University · Shanghai, Jingan · NCT07923812

• Automated language analysis to help diagnose neurodegenerative diseases

  A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.

  Recruiting Istituti Clinici Scientifici Maugeri SpA · Bari · NCT07906769

• LIFU to Help Sleep and Amyloid Reduction in Older Adults with Cognitive Impairment

  A wearable ultrasound device (ATTN201) is being tested to see if it’s safe and easy to use for people 65 and older with mild cognitive impairment and amyloid buildup.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07866768

• Urolithin A for early Alzheimer’s disease: a test with a nutritional supplement

  This trial tests whether taking urolithin A in addition to standard care helps people with early Alzheimer’s or mild cognitive impairment show better biomarkers and cognition.

  Recruiting University Hospital, Akershus · Prague · NCT07842146

• Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease

  This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT07803055

• Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases

  This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07798700

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.